The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jaime Feliu

Medical Oncology Department

Hospital Universitario La Paz

IDIPAZ

Pº de Castellana 261

Spain

[email]@*.madrid.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medical Oncology Department, Hospital Universitario La Paz, IDIPAZ, Pº de Castellana 261, Spain. 2004 - 2011
  • Medical Oncology Department, Hospital La Paz/Autónoma University School of Medicine. IdiPAZ. RETIC, P degrees de la Castellana, Madrid 261- 28046, Spain. 2010

References

  1. Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. Feliu, J., Borrega, P., León, A., López-Gómez, L., López, M., Castro, J., Belda-Iniesta, C., Barriuso, J., Martínez, V., González-Barón, M. Cancer Chemother. Pharmacol. (2011) [Pubmed]
  2. Development and validation of a prognostic nomogram for terminally ill cancer patients. Feliu, J., Jiménez-Gordo, A.M., Madero, R., Rodríguez-Aizcorbe, J.R., Espinosa, E., Castro, J., Acedo, J.D., Martínez, B., Alonso-Babarro, A., Molina, R., Cámara, J.C., García-Paredes, M.L., González-Barón, M. J. Natl. Cancer Inst. (2011) [Pubmed]
  3. Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer. Feliu, J., Safont, M.J., Salud, A., Losa, F., García-Girón, C., Bosch, C., Escudero, P., López, R., Madroñal, C., Bolaños, M., Gil, M., Llombart, A., Castro-Carpeño, J., González-Barón, M. Br. J. Cancer (2010) [Pubmed]
  4. Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas. Feliu, J., Sáenz, J.G., Jaráiz, A.R., Castañón, C., Cruz, M., Fonseca, E., Lomas, M., Castro, J., Jara, C., Casado, E., León, A., Barón, M.G. Cancer Chemother. Pharmacol. (2006) [Pubmed]
  5. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. Feliu, J., Salud, A., Escudero, P., Lopez-Gómez, L., Bolaños, M., Galán, A., Vicent, J.M., Yubero, A., Losa, F., De Castro, J., de Mon, M.A., Casado, E., González-Barón, M. Br. J. Cancer (2006) [Pubmed]
  6. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. Feliu, J., Escudero, P., Llosa, F., Bolaños, M., Vicent, J.M., Yubero, A., Sanz-Lacalle, J.J., Lopez, R., Lopez-Gómez, L., Casado, E., Gómez-Reina, M.J., González-Baron, M. J. Clin. Oncol. (2005) [Pubmed]
  7. Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer. Feliu, J., Castañón, C., Salud, A., Mel, J.R., Escudero, P., Pelegrín, A., López-Gómez, L., Ruiz, M., González, E., Juárez, F., Lizón, J., Castro, J., González-Barón, M. Br. J. Cancer (2005) [Pubmed]
  8. Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer. Feliu, J., Vicent, J.M., García-Girón, C., Constela, M., Fonseca, E., Aparicio, J., Lomas, M., Antón-Aparicio, L., Dorta, F.J., Gonzalez-Baron, M. Br. J. Cancer (2004) [Pubmed]
 
WikiGenes - Universities